Stocks and Investing
Stocks and Investing
Fri, December 16, 2022
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Edward Tenthoff Maintained (ALNY) at Buy with Increased Target to $253 on, Dec 16th, 2022
Edward Tenthoff of Piper Sandler, Maintained "Alnylam Pharmaceuticals, Inc." (ALNY) at Buy with Increased Target from $226 to $253 on, Dec 16th, 2022.
Edward has made no other calls on ALNY in the last 4 months.
There are 10 other peers that have a rating on ALNY. Out of the 10 peers that are also analyzing ALNY, 4 agree with Edward's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Mani Foroohar of "SVB Leerink" Maintained at Hold with Increased Target to $145 on, Monday, November 7th, 2022
- Matthew Harrison of "Morgan Stanley" Maintained at Hold with Decreased Target to $210 on, Friday, October 28th, 2022
- Jessica Fye of "JP Morgan" Maintained at Hold with Decreased Target to $200 on, Monday, October 24th, 2022
- Gary Nachman of "BMO Capital" Maintained at Hold with Increased Target to $200 on, Friday, September 9th, 2022
These are the ratings of the 6 analyists that currently disagree with Edward
- Patrick Trucchio of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $415 on, Wednesday, November 2nd, 2022
- Salveen Richter of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $270 on, Friday, October 28th, 2022
- Gena Wang of "Barclays" Maintained at Buy with Decreased Target to $236 on, Friday, October 28th, 2022
- Maury Raycroft of "Jefferies" Maintained at Strong Buy with Increased Target to $232 on, Monday, October 3rd, 2022
- Luca Issi of "RBC Capital" Maintained at Buy with Increased Target to $250 on, Tuesday, September 20th, 2022
- Leland Gershell of "Oppenheimer" Maintained at Buy with Increased Target to $256 on, Friday, September 9th, 2022
Contributing Sources